Episode 7: A View On Spray-Drying mRNA-based Therapies

Delivering mNRA Therapies: A Bullseye for Asthma and Future Pandemics

In this episode of A View On, we speak with Carsten Rudolph, CEO and co-founder of Ethris, about a novel spray-dried mRNA therapy that targets local immunity in the lungs. Designed to restore interferon lambda signaling in asthma patients, the therapy is also room temperature-stable and virus-agnostic—making it a promising candidate for pandemic preparedness. Tune in to hear how formulation science, lipid carriers, and inhalable delivery are reshaping the future of respiratory care.